









Destroy another fetus now 
We don’t like children anyhow 
Leonard Cohen, The Future 
 
Dance me to the children who are asking to be born 






Let’s start by the beginning, that is with the middle. For a bit more than a year, I have been 
immersed in the middle of the GIGA biomedical research center, located in the University 
hospital in Liège. I happened to be around when a particular protocol was introduced step-by-step 
in medical practice, and this protocol carries forth non-invasive prenatal testing – NIPT, which 
most notably allows to detect Down syndrome — Trisomy 21. “Non-invasive” simply means that 
you do not need to take biological sample from the fetus itself but that you can get some 
information only by taking a sample of the mother’s blood. So I thought I’d go along with NIPT 
and follow its introduction into the clinical setting.  
As it turns out, NIPT is widely heralded as a great achievement of medical genomics. Much 
money went through the sequencing and assemblage of a Reference Genome under the aegis of 
the Human Genome Project, finally some medical applications come out of it! It is no wonder 
that a “milieu” where a university hospital is intimately associated with a large biomedical center 
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developed an early focus on genetics, then genomics, and now attempts to account for all the 
research carried forth. Not only is medical progress down the road, but also the fulfilling on 
somehow exorbitant promises that have been made before. As in many similar institutions of the 
civilized world, NIPT timely arrived to satisfy a thirst for actual medical genomics.  
So please forgive me for sticking to the ground. I will not raise higher impacts or promises of 
medical genomics, nor will I impact directly the shifts and problems raised with respect to public 
health systems and solidarity. It’s not that I don’t care. Simply I do not wish to anticipate and 
jump too quickly into well-bounded and clearly defined sociological arguments. Instead, I would 
like to propose a technical contrast between the most routinized practice of amniocentesis, the 
“invasive” diagnosis as it were, and the “non-invasive” one that is the NIPT, so as to question 
how these technologies operate and what we can learn from it.  
Weighing	the	stakes	
But before I get to it, I would like to address the very sensitive, vital stake of prenatal testing, the 
famous “elephant in the room” Stefan talked about during his keynote speech: abortion. The 
deliberate termination of pregnancies. Of course, this has nothing to do, in my view, with a moral 
problem, but rather with a technical, pragmatic one: how to relate to unborn fetuses? How to 
confront the absence of these lives which will never come to being? In a beautiful text, William 
James raised the dramatic question: “is life worth living?”. His answer was clear-cut: “life is not 
worth living the whole army of suicides declare” (The will to believe). It follows that no one 
holds a right to embrace or dismiss a singular life, as a value in itself, except for those who are 
ready to endorse the consequences of such a dismissal.  
When it comes to fetuses, this creates a hole in the realm of the thinkable. It is a difficulty for 
someone like me who has been nurtured with relational ontology, i.e. an idea that human as well 
as non-human beings exist and consist through their multiple relationships and interdependencies 
(Cléo). This perspective somehow faces… an abrupt shortcoming, because abortion precedes the 
very possibility of the relationship. In a magnificent paper, “Inheriting from the incubator”, 
Gabriel Dorthe reflects on his experience as a highly premature baby put into an incubator. With 
a lot of care, he unfolds the tenuous, precarious, fragile linkages between the newborn and the 
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surrounding technological apparatus, the controlled environment which aims at keeping him 
alive. Nothing like that much care and precaution is rendered possible by “null and void” 
existences. Yet, I would hate the idea that we are left with no other choice than naturalizing 
“abortion as usual” or, at least, rendering this harsh decision unproblematic.   
Of course, this problem is not specific to NIPT. It is the problem of abortion in general, as the 
most dramatic consequence of prenatal testing. However, I think it matters to depart from this 
gap, this hole in the order of possibilities, to properly address what is at stake. Isabelle Stengers 
helps me out in order to get out of this dead end. She once wrote (my translation): “(…) we can’t 
address ourselves to something so as to question its properties without engaging into a 
relationship with this thing. The demands associated with the relationship take a critical value as 
long as the thing which is being questioned is alive — biologists cannot or should not be able to 
elude the fact that they themselves are living beings” (in Combes 2011, p. 5).  
So, how do we get in relation with living entities before they come into being? How do we 
address ourselves to fetuses? With Stengers, I would like to underline the importance of the 
modalities of the relation, as they technically play out in both amniocentesis and NIPT (no matter 
how these two technologies combine or exclude each other, it is not my point).  
Drawing	a	technical	contrast	
Amniocentesis is a means of diagnosis which is qualified as “invasive”. It is performed following 
an early testing tool called combined test. This test takes into consideration different risk factors 
through an echography and an analysis of some the mother’s markers. If the combined test 
signals a risk, then amniotic fluid (about 20 ml) can be sampled, at the earliest by the 14-16th 
week of pregnancy. This sampling is performed directly in the amniotic sac which induces the 
risk of premature birth defect. Then the sample goes through a rather long process: it undergoes a 
cell culture process in the hospital laboratory. This cell culture lasts for about 4 weeks, by the end 
of which it becomes possible to stabilize the cells and stain them. This allows for looking at the 
actual chromosomes by optical means. That way, it becomes possible to optically detect whether 
the fetus bears a supernumerary copy of the 21st chromosome – which indicates that the fetus 
suffers from the Down syndrome condition or not.    
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By contrast, the NIPT diagnoses reaches this target by “non-invasive” means. But it gets slightly 
more complicated! As I said, with NIPT, the presence or absence of the Down syndrome will be 
detected from a sample of the mother’s blood through so-called “Next-Generation Sequencing” 
— NGS. “Sequencing” is the name of the technique itself, I will get to it in a short while. In the 
mother’s blood circulate fragments of the fetus’ DNA which is known as “cell-free fetal DNA”. 
But how to distinguish the mothers’ DNA from the fetus’ DNA?  
The first thing you need to do is to enter that room of DNA extraction (pictures). The DNA must 
be obtained and purified through PCR techniques (polymerase chain reaction), which amplifies 
the DNA “signal” through a cycle of thermic operations (the biological sample is heated and 
cooled repeatedly). The substance resulting from this process is then positioned on a chip 
alongside a copy of the “reference human genome”. How this “reference genome” was built and 
is regularly updated in new “builds” is in itself a story in which I will not dig deeper here. 
Enough is to say that current version of the Reference Genome, as released by the Genome 
Reference Consortium, is build 37 patch 13. You don’t tell about humanism 2.0… This reference 
stands for the human genome in general; hence it is deemed to aptly represent the human as a 
unified species. This “reference genome” serves as a unified backdrop upon which you may 
contrast the singularities of the particular organism you are looking at.  
What you want to detect is the presence or absence of a chromosomal “disorder”, or “anomaly” 
that point out to the Down syndrome. It is not like it is possible to separate physically the 
mother’s DNA, on one side, and the fetus’ DNA on the other. The point here consists in detecting 
a significant amount of third copies of the 21st chromosome. If the mother is not affected by the 
Down syndrome, then it must be the fetus… (although it is not that simple since there can be 
cases of “mosaicism” where the mother bears some therapeutically insignificant chromosome 
anomalies). So what you will look at, here, is at a frequency of repetitions, a number of 
occurrences, a threshold of supernumerary copies of the 21st chromosome, which indicate with a 
fair reliability that the fetus probably bears the Down Syndrome.  
[DIA] Carrying forth this contrast between the fetus’ cell-free DNA and the Reference genome is 
the job of Next-Generation Sequencing techniques. To do that, you put your chip into the 
sequencer per se (show image: ho no, sorry, that one is six months old) and the sequencer will 
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literally “read” the chip, it will recognize a number of base pairs made of A, G, C, T [DIA]. At a 
first glance, “sequencing” looks like a “sequence” in an animated movie; you have picked up all 
your disparate drawings that lie on the floor, you have sort them out and then you try to order 
them so as to make something coherent out of this mess. But unlike an animated movie or a 
puzzle, with NGS you don’t really know the scenario in advance, nor can you embrace the result 
at a glance, because it is way too wide. How to proceed then?  
[DIA] Among other processes, there are two tools in particular which intervene as operators to 
perform this relationship between the “reads” from the singular organism, and the “reads” of the 
reference genome. The first one is an software known as the Burrows-Wheeler Aligner (BWA) 
made of algorithms (http://bio-bwa.sourceforge.net/). BWA includes a “trimming algorithm”, i.e. 
a machine learning technique which roughly simplifies too complex results from a training set, by 
eliminating as much as possible insignificant data. This occurs through successive running 
decision trees which eliminate the options that have a low power of classification. That way, the 
“noise” is eliminated and the level of information deemed relevant raised accordingly. What 
comes out of it is referred to as “low-divergent” data. Passed this operation of conformation, 
reads after reads, it will inventory; what do we have here? It maps all the base pairs, grouping 
them into regions, constituting a territory. Then it compares with the reads from the reference 
genome so as to align them in the “appropriate” order. For each read, it seeks to correspond to the 
Reference genome.  
Those successive operations are known as “data cleaning”, “mapping” and “aligning”. These are 
geographical in a sense; one needs to decide which elements will be deemed important to 
represent this territory that is the body, to draw a map to orient oneself and then adjust it to the 
reality, and to making sure that it fits. Except that here, it is impossible to come back to the body 
itself to check the proper adequacy of the map to the territory, because there is no way you can 
relocate physically all those reads from the sequencer in the mothers’ body or in the amniotic 
fluid. Instead, you will relate it to a previously known assemblage, more or less valid and robust, 
that is the reference genome — another map, in fact, but which has been obtained through so 
many consolidations that it can now be relied upon to provide the kind of contrasts NIPT seeks.    
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[DIA] The second operation consists in applying an analytical framework which enables sense-
making out of this data. The GATK framework performs a sort of browsing tools. It has been 
developed by the Broad Institute, based in Cambridge (MA) and jointly hosted by MIT and 
Harvard. Depending on what you look for, it will allow you to seek and target specific elements 
in some predetermined “regions” of the genome. It provides a compass for the location of 
medically significant information. “At the heart of the GATK is an industrial-strength 
infrastructure and engine that handle data access, conversion and traversal, as well as high-
performance computing features. On top of that lives a rich ecosystem of specialized tools, called 
walkers”1. One could not say more eloquently the need to explore that vast territory just rendered 
visible under the form of a map.  It illustrates well that they wander around the genome territory, 
trying to find significant events, even though each of these tools has a specific way of questioning 
the genomic landscape into which they are immersed. In that sense, GATK takes bunches of 
single reads and attempts to relate them to the well-known population of reads that is the 
Reference genome. 
After all this journey, of course, you need to make sure that all of this is included in a medical 
protocol which delivers valid results which you can assess, control, and so on, and this is a whole 
other story. But simply I wish to emphasize that, really, NGS techniques can be qualified as 
“populational operations” because of the countless moves they make back and forth between a 
singular organism and the reference genome of the human species. They select relevant reads, 
conforms them to a preexisting Reference, distribute and align them accordingly, drawing similar 
regions and allocating similarities and differences.  
Conclusion:	nothing	changes	but	everything	changes	
So now, how to characterize these two modes of knowledge production, aka how to compare 
those two different ways of relating to the unborn?  
                                                   
1 https://www.broadinstitute.org/gatk/about/.  
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Amniocentesis is addressed to a fetus: do you bear the Down syndrome condition? The stake is: 
to determine whether a fetus itself bears this condition or not.  
NIPT is also addressed to a fetus but the question is at all different: how do you relate to a 
population? So this question constitutes “population” as a mandatory passage point, both as a 
reference standard and as its local declination. The stake is: to detect an anomaly, i.e. a threshold 
of chromosome depletions which differs from the standard in the population.  
This locates the trial at a whole different level; amniocentesis put each singular organism itself to 
trial (in terms of optical detection), while NIPT integrates singular organisms into a broader 
frame to which it needs to adjust statistically speaking (in terms of threshold); 
In so doing, NIPT establishes a background upon which a contrast can easily be drawn in the case 
of Down syndrome (bioinformatician: could find it with gloves). But the infrastructure makes a 
detour by the Reference genome to draw its contrasts, and therefore opens up a space through 
which many more potential information on the fetus could be gathered. Potentially.  
The consequence is that we move from a situation of scarcity with the information provided by 
the organism, to a situation characterized by the wealth of potential information. I’m tempted to 
say that, currently, it doesn’t matter if indeed this potential information is rendered actual by 
further prenatal testing protocols or next next-generation tools. In the here and now, it simply 
matters that such a potential space lies wide open. 
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